Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients: Case series of four patients

Internal Medicine Journal

Volumn 43, Issue 3, 2013, Pages 328-333

  Nwaba, A ^a   MacQuillan, G ^a,b   Adams, L A ^a,b   Garas, G ^a,b   Delriviere, L ^a   Augustson, B ^c   Deboer, B ^c   Moody, H ^c   Jeffrey, G P ^a,b  

^a Western Australian Liver Transplant Unit   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Adverse drug reaction committee; Living donor liver transplant; Orthotopic liver transplantation; Plasma exchange; Thrombotic microangiopathy; Ultra large von Willebrand factor

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; MYCOPHENOLIC ACID; PARACETAMOL; PREDNISOLONE; TACROLIMUS;

ARTICLE; BONE MARROW TRANSPLANTATION; COHORT ANALYSIS; DRUG OVERDOSE; DRUG WITHDRAWAL; FOLLOW UP; HEALTH SERVICE; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MICROCIRCULATION; MORTALITY; OUTCOME ASSESSMENT; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; WILSON DISEASE;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACROLIMUS; THROMBOTIC MICROANGIOPATHIES; YOUNG ADULT;

EID: 84874381239     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12048     Document Type: Article

References (31)

1. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.
2. Ramasubbu K, Mullick T, Koo A, Hussein M, Henderson JM, Mullen KD etal. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipient: a case-based review. Transpl Infect Dis 2003; 5: 98-103.
3. Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 1997; 89: 1224-1234.
4. Moake JL, McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med 1989; 87: 9N-15N.
5. Cohen JA, Brecher ME, Bandarenko N. Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura. J Clin Apher 1998; 13: 16-19.
6. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle AP, Brenner B etal. von Willebrand factor cleaving protease in thrombotic thrombocytopenic purpura and haemolytic - uremic syndrome. N Engl J Med 1998; 339: 1578-1584.
7. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-1594.
8. Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K. Structure of von Willebrand cleaving protease (ADAMTS-13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001; 276: 1059-1063.
9. Remuzzi G, Imberti L, Gaetino DG. Prostacyclin deficiency in thrombotic microangiopathy. Lancet 1981; 2: 1422-1423.
10. Kwaan HC. Role of fibrinolysis in thrombotic thrombocytopenic purpura. Semin Hematol 1987; 24: 101-109.
11. Nishi H, Hanafusa N, Kondo Y, Nangaku M, Sugawara Y, Makuuchi M etal. Clinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy. Clin J Am Soc Nephrol 2006; 1: 811-819.
12. Moake JL. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Best Pract Res Clin Haematol 2009; 22: 567-576.
13. Rose M, Rowe JM, Eldor A. The changing course of thrombotic thrombocytopenic purpura and modern therapy. Blood Rev 1993; 7: 94-103.
14. Wyllie BF, Garg AX, McNab J, Rock GA, Clark WF. Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange. Br J Haematol 2006; 132: 204-209.
15. Lara PN Jr, Coe TL, Zhou H, Fernando L, Holland PV, Wun T. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Am J Med 1999; 107: 573-579.
16. Tamura S, Sugawara Y, Matsui Y, Kishi Y, Akamatsu N, Kaneko J etal. Thrombotic microangiopathy in living-donor liver transplantation. Transplantation 2005; 80: 169-175.
17. Matsusaki T, Morimatsu H, Sato T, Sato K, Mizobuchi S, Morita K. Thrombotic microangiopathy after living-donor liver re-transplantation. J Anesth 2010; 24: 614-617.
18. Lee CH, Chen CL, Lin CC, Yang CH, Cheng YF, Wang MC etal. Plasma exchange therapy for thrombotic thrombocytopenic purpura in paediatric patients with liver transplantation. Transplant Proc 2008; 40: 2554-2556.
19. Singh N, Gayowski T, Marino RI. Hemolytic uremic syndrome in solid-organ transplant recipients. Transpl Int 1996; 9: 68-75.
20. Brown Z, Neild GH. FK-506 and haemolytic uraemic syndrome. Lancet 1990; 335: 412.
21. Mach-Pascual S, Samii K, Beris P. Microangiopathic haemolytic anaemia complicating FK506 (tacrolimus) therapy. Am J Hematol 1996; 52: 310-312.
22. Rerolle JP, Akposso K, Lerolle N, Mougenot B, Ponnelle T, Rondeau E etal. Tacrolimus - induced haemolytic uremic syndrome and end-stage renal failure after liver transplantation (case report). Clin Transplant 2000; 14: 262-2655.
23. Gatti S, Arru M, Reggiani P, Como G, Rossi F, Fassati LR etal. Successful treatment of haemolytic uremic syndrome after liver - kidney transplantation. J Nephrol 2003; 16: 586-590.
24. Schirren CA, Berghaus TM, Sackmann M. Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver failure. Ann Intern Med 1999; 130: 163.
25. Dabrowska E, Jablonska-Kaszewska I, Ozieblowski A, Porzezinska B, Falkiewicz B. Liver transplantation in a patient with haemolytic syndrome in course of fulminant Wilson's disease. Klinika Chorob Wewnetrznych, Endokrynologii i Zaburzen Hemostazy Akademii Medycznej w Gdansku. Prezl 2000; 57: 362-365.
26. Levandovsky M, Harvey D, Lara P, Wun T. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients. J Hematol Oncol 2008; 1: 23.
27. Waiser J, Budde K, Rudolph B, Ortner MA, Neumayer H. De novo haemolytic uraemic syndrome postrenal transplant after cytomegalovirus infection. Am J Kidney Dis 1999; 34: 556-559.
28. Nolasco LH, Gushiken FC, Turner NA, Kathlani TS, Pradhan S, Dong JF etal. Protein phosphatase 2B inhibition promotes the secretion of von Willebrand factor from endothelial cells. J Thromb Haemost 2009; 7: 1009-1018.
29. Nakazawa Y, Hashikura Y, Urata K, Ikegami T, Terada M, Yagi H etal. Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report. Liver Transpl 2003; 9: 1328-1333.
30. Mal H, Veyradier A, Brugiere O, Da Silva D, Colombat M, Azoulay E etal. Thrombotic microangiopathy with acquired deficiency in ADAMTS 13 activity in lung transplant recipients. Transplantation 2006; 81: 1628-1632.
31. Trimarchi HM, Truong LD, Brennan S, Gonzalez JM, Suki WN. FK506-associated thrombotic microangiopathy: report of two cases and the review of the literature. Transplantation 1999; 67: 539-544.